Investment Strategies 18 February 2026 - 24 February 2026

Coherent Corp shares rose 0.3% to $248.89 in after-hours trading Monday after Morgan Stanley raised its price target to $250 from $200 while maintaining an Equal-Weight rating. The stock remains near record highs, following strong demand in its datacenter segment and a recent upbeat quarterly forecast. Coherent closed at a record $248.18 on Feb. 20 and has traded as high as $252.49. Investors await a March 17 technology briefing.

Opendoor shares fell 2.2% to $4.89 in premarket trading Monday, trimming Friday’s 7.5% rally. The company reported a $1.096 billion net loss for Q4, with revenue down to $736 million from $1.084 billion a year earlier. Homes purchased rose 46% from the prior quarter. CFO Christina Schwartz sold 74,248 shares on Feb. 17 in a tax-related transaction.

Dubai’s DFM General Index closed Friday down 0.26% at 6,590.53 points, with banks leading losses amid U.S.-Iran tensions and softer oil. Dubai Islamic Bank dropped 2.2%, Emirates NBD fell 0.7%. Oil eased 0.4% to $71.38 a barrel. Emirates NBD’s ex-dividend date is Feb. 26, while investors await global inflation data next week.

Robinhood reported end-January platform assets of about $324 billion and repurchased $173 million in shares through Feb. 17. Funded accounts rose to 27.2 million, with net deposits of $4.5 billion. Goldman Sachs cut its price target to $111 but maintained a buy rating. Shares closed Friday up 0.6% at $76.11.

Carvana shares closed up 1.2% at $336.62 on Friday after a volatile week. The company missed fourth-quarter profit estimates due to higher reconditioning and depreciation costs, and warned those expenses could remain elevated in Q1. Short interest stands at about 10.7% of free float, with 14.84 million shares sold short as of Feb. 17, according to Ortex. Carvana did not provide specific targets for sales or adjusted EBITDA.

JPMorgan shares rose 0.9% to $310.79 Friday after the bank named senior leaders to oversee a $1.5 trillion security and resiliency initiative. The program will target strategic manufacturing and defense, with up to $10 billion in direct investments. Investors remain focused on tariffs, interest rates, and inflation signals heading into Monday.

Kruk shares fell 9.26% to 451 zlotys Friday, marking the steepest drop on the WIG20 after the company posted preliminary Q4 net profit of 208 million zlotys and cash EBITDA of 658 million zlotys. The full report is due Feb. 26, with a management call set for Feb. 27.

Thailand’s SET Index fell 0.95% to 1,479.71 on Friday, ending a four-day winning streak. Foreign investors were net buyers, but local institutions sold more, pushing the market lower. Turnover reached 90.5 billion baht, with heavy trading in TRUE, Bangkok Bank, PTT, Kasikornbank, and Krung Thai Bank. Traders are watching domestic politics, earnings, and MSCI index changes for next week.

Deutsche Börse shares closed Friday at 219.90 euros, up 1.62%, as the group began a share buyback of up to 500 million euros through July 31. About 706,500 shares traded during the session. The buyback started Feb. 20 and will follow EU “safe harbour” rules, with purchases executed via Xetra. Investors await early disclosures and Q1 results in late April.

Eli Lilly shares dropped 1.6% to $1,006.78 Friday morning, underperforming the S&P 500 ETF’s 0.6% gain. Barclays began coverage with an Overweight rating and a $1,350 target, citing strong prospects for GLP-1 weight-loss drugs. Novo Nordisk’s U.S. shares fell 1.9%. Lilly reported new data showing long-term remission with Omvoh in Crohn’s disease and announced a $100 million deal with CSL for clazakizumab rights.

GRAIL Inc shares plunged 47.6% to $53.20 in U.S. premarket trading after its NHS-Galleri trial failed to meet the main goal of reducing late-stage cancers. The study, involving 142,000 people in England, showed a drop in Stage IV diagnoses but not a statistically significant combined drop in Stage III and IV cases. Galleri is not FDA approved. Fourth-quarter revenue rose 14% to $43.6 million.

Walmart shares fell 1.4% to $124.82 in after-hours trading Thursday after reporting fiscal Q4 revenue of $190.7 billion, up 5.6%. U.S. comparable sales rose 4.6%, e-commerce jumped 27%, and the company authorized a $30 billion share buyback. Walmart forecast 2027 net sales growth of 3.5%–4.5% and raised its annual dividend 5% to $0.99 per share.

Analog Devices shares fell 0.7% to $343.84 Thursday, reversing some of Wednesday’s post-earnings surge. The company forecast second-quarter revenue above Wall Street estimates and raised its dividend 11%. Chip stocks broadly declined, with Texas Instruments and Microchip Technology both down more than 2%. Wall Street analysts raised price targets, with Needham upgrading ADI to “buy.”

Global-e Online shares fell 2.3% to $34.00 premarket Thursday after a 17.2% surge the previous session. The company reported Q4 revenue of $336.7 million, up 28%, and net profit of $62.5 million. It forecast 2026 revenue of $1.21–$1.27 billion and adjusted EBITDA of up to $284 million. BofA raised its price target to $52 and kept a Buy rating.

Centrica shares dropped 7% after the company paused share buybacks and cut its 2026 profit outlook for its energy trading arm. The British Gas owner said its transformation programme will cost £600 million and lowered expected Optimisation earnings to £250 million. Adjusted EBITDA for 2025 fell to £1.417 billion from £2.305 billion. Centrica proposed a final dividend of 3.67p per share.

Analog Devices shares rose 2.6% to $346.37 in after-hours trading after reporting fiscal Q1 revenue up 30% to $3.16 billion and adjusted EPS of $2.46, both above forecasts. The company cited strong industrial demand and record data-center orders, and raised its quarterly dividend by 11% to $1.10 a share.